CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Jinling Pharmaceutical Company Limited Company Snapshot
Jinling Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Jinling Pharmaceutical Company Limited with three other companies in this sector in China: Zhuzhou Qianjin Pharmaceutical Co., Ltd. (2017 sales of 3.18 billion Chinese Renmimbi [US$459.62 million] of which 53% was Medicine Manufacturing), Heilongjiang ZBD Pharmaceutical Co Ltd (3.14 billion Chinese Renmimbi [US$453.64 million] of which 62% was Pharmaceutical Industry), and Guangdong Taiantang Pharmaceutical Co Ltd (3.23 billion Chinese Renmimbi [US$467.06 million] of which 49% was Medicine Wholesale & Retail).

Sales Analysis. Jinling Pharmaceutical Company Limited reported sales of 3.19 billion Chinese Renmimbi (US$460.99 million) for the year ending December of 2017. This represents a decrease of 10.8% versus 2016, when the company's sales were 3.58 billion Chinese Renmimbi. Contributing to the drop in overall sales was the 23.2% decline in Other, from 122.67 million Chinese Renmimbi to 94.17 million Chinese Renmimbi. There were also decreases in sales in Medicine Manufacturing (down 17.6% to 2.16 billion Chinese Renmimbi) . However, these declines were partially offset by the increase in sales of Medical Service (up 12.3% to 935.63 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Jinling Pharmaceutical Company Limited
  Stock Performance Chart for Jinling Pharmaceutical Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (10/12/2018): 6.13
(Figures in Chinese Renmimbi)
1 Week n/a   13 Weeks -9.2%  
4 Weeks -18.0%   52 Weeks -43.0%  
 
Jinling Pharmaceutical Company Limited Key Data:
  Ticker: 000919 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 3,191,811,864
(Year Ending Jan 2018).
Employees: 5,088
  Currency: Chinese Renmimbi Market Cap: 3,089,520,000
  Fiscal Yr Ends: December Shares Outstanding: 504,000,000
  Share Type: A Gu Closely Held Shares: 304,918,599
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.